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ABSTRACT 
BACKGROUND: Smoking is considered to be  initiators of dysplastic changes 
in the oral mucosa. 
AIM: The aim of this study was to determine and compare the alteration in 
apparently normal buccal mucosal cells in smokers and non –smokers due to the 
effect of tobacco by assessing silver stained nucleolar organiser regions. 
(AgNOR) 
MATERIALS AND METHODS: The study comprised of  75 subjects divided 
into two groups with 25 subjects having smoking habit and 50 subjects who 
were non smokers. Cytological smears were taken from each subject with the 
help of a cytological brush. The smear was wet fixed and stained with AgNOR 
and assessed for nucleolar organising regions.50 cells were counted in each 
slide. 
RESULTS: Unpaired T-test and Pearson’s R correlation test was applied. 
Cytological changes in smokers revealed an increase in mean AgNOR  in 
comparison with non-smokers. 
CONCLUSION: Tobacco smoking  produce alterations in apparently normal 
buccal mucosal cells, which may cumulatively lead to carcinomatous changes. 
Results of these changes may be used as  an educational tool  in cessation of  
smoking in the general population. 
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INTRODUCTION 
Medical science has made considerable progress with respect 
to infectious diseases. In case of carcinoma, there is a lot to be 
achieved, although a good deal of innovations and lifesaving 
therapies have been discovered. In case of oral cancers, it begins 
with use of tobacco. It is the powdered leaf of a plant which was 
used in a Y shaped piece of cone called “Tobago”. 
Malignancy of the oral cavity is the sixth most common 
malignancy worldwide.1 It has a dismal 5-year survival, except when 
it is detected in early stages. The established method for diagnosis 
is by biopsy, which is carried out only when patient is symptomatic. 
Hence it is of little value in detecting at an early stage and 
preventing the progression. 
In Indian subcontinent, oral cancer is one of the most 
common forms of cancer. Mostly they are squamous cell 
carcinomas. It is a major public health problem. The habit of 
tobacco smoking is associated with leukoplakia. As oral cancers 
arise from premalignant lesions, the effect of early screening 
reduces the risk for oral cancers. 
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The prognosis is good if detected earlier, in case of mouth 
cancers. Many methods have been used to identify pre-malignant 
lesions as a marker of impending malignancy. They are assessment 
of mitosis, DNA ploidy status, DNA and RNA in situ hybridization, 
monoclonal antibodies to detect proliferation related antigens. The 
issue is, they are expensive, time consuming and need sophisticated 
equipment. 
Nucleolar organizing regions are loops of DNA, that 
transcribe to the ribosomal RNA, which in turn results in synthesis 
of proteins by the cell. Nucleolar organizing regions are correlated 
with cellular proliferation. 
AgNOR staining is an inexpensive and easy method for 
identifying nucleolar organizing region with this idea, our present 
study has been conducted to assess the accuracy of AgNOR as a 
proliferation marker in buccal smear. 
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“Doctors, nurses, midwives, dentists, pharmacists, 
chiropractitioners, psychologists and all other professionals 
dedicated to health can help people change their behavior. They 
are on the frontline of tobacco epidemic and collectively speak 
to millions of people.”   
Quote by DR.Lee jong-wook,  
Former Director General, WHO(2005) 
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AIM OF THE STUDY 
To determine and compare the alteration in apparently normal 
buccal mucosal cells in smokers and non -smokers due to the effect 
of tobacco by assessing silver stained nucleolar organizer regions 
(AgNOR) 
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REVIEW OF LITERATURE 
ILL EFFECTS OF SMOKING 
People can be broadly classified as non -smokers and smokers 
.Further,they are subclassified as 
 Non smokers - a) Never smokers   
                         b) Former smokers 
 Smokers        - a) Minimal-who smoke <15cigarettes / day 
                        b) Moderate-who smoke between  
      15-25cigarettes / day 
   c) Heavy –who smoke >25 cigarettes / day2 
They are prone to a wide range of diseases. Smoking can lead 
to recurrent pulmonary infections, COPD, pulmonary tuberculosis, 
peripheral vascular diseases, myocardial infarction, stroke, hip 
fracture. It can have a major role in the etiopathogenesis of various 
cancers. In 20th century it killed about 100 million People 
worldwide. 
There is a well-known correlation between smoking and 
cancer of various organs like lung, bladder, oral cavity, larynx. 
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MECHANISM 
The cancer causation by cigarette smoking follows these steps 
 (1)  Exposure to the carcinogens. 
 (2) Establishment of bonds between carcinogens and DNA.  
 (3)  Accumulation of somatic mutations in genes.   
Each puff of cigarette has many compounds, of which 60 are 
well known carcinogens. These carcinogens can be subdivided into 
various classes, including, aromatic amines, volatile organic 
compounds, polycyclic aromatic hydrocarbons (PAH). The metabolites 
of these carcinogens are elevated in blood, breath and mainly 
urine.3 
Most carcinogens undergo a metabolic activation process and 
change them to metabolites which attach to DNA. This results in 
production of DNA adducts. Metabolic activation of cigarette carcinogen 
requires P-450s 1A2, 2A13.  The induction of P-450 is critical for 
cancer susceptibility in smokers4. Metabolic detoxification is carried 
out by enzymes like uridine-5′-disphosphate-glucuronosyltransferases 
(UGTs), glutathione-S-transferases (GSTs). The equation between 
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detoxification and activation of carcinogens shows considerable 
variation among persons and affects susceptibility to malignancies. 
The carcinogens, once activated results in DNA adduct 
production, which is vital in the carcinogenic process. A few can 
directly form DNA adducts. Studies found that adduct levels is 
elevated in smokers .5 
The repair system removes DNA adducts. They are direct 
repair of DNA bases by alkyl transferases, double-strand break 
repair, and mismatch repair6. If these repair enzymes do not 
function properly. These adducts may remain and raise the chance 
of producing somatic mutations. 
Persistent DNA adducts miscoding during replication of  
DNA.  Particular DNA adducts leads to specific somatic mutations. 
KRAS and Tp53 oncogenes are subjected to such changes.  
Gene mutations results in a change which disturbs the normal 
proliferation of cells and leads to cancer. The phenomenon of 
apoptosis counteract against these mutational events and 
eliminating DNA which are damaged. The balance between process 
of apoptosis and events suppressing apoptosis plays an important 
role in tumor proliferation.    
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Nicotinic receptors are the sites where nicotine and 
nitrosamines bind. These activate protein kinase A and protein 
kinase B7. Smoking stimulates production of EGFR8 and COX-2, 
which results in changes leading to cell proliferation. These 
products enhance the carcinogenicity of these constituents of 
tobacco. The changes which carry an increased risk of cancer, are 
reverted on cessation of smoking. 
An important pathway of enzymatic hyper methylation, which 
is termed as epigenetic changes9. It produces gene silencing of 
mainly tumor suppressor genes and can lead to proliferation of cells 
which are unregulated.  
CARCINOGEN EXPOSURE 
The exposure of smokers to these carcinogenic compounds is 
1.4 to 2.2 milligrams per cigarette. N-nitrosamine and aromatic 
amines, PAHs are a few carcinogens which are quiet potent and less 
in quantity. Acetaldehyde and isoprene are higher in quantity, but 
their potency is quiet less. 
PAHs are incomplete combustion products. Some PAHs such 
as benzo[a]pyrene (B (a)P)  have a very high ability to produce 
malignancies.10 
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Similar to PAH are heterocyclic compounds and they contain 
nitrogen. one of the compound, which is a liver carcinogen is 
furan.10                            
A group of potent carcinogens are N-nitrosoamines.  
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N’-
nitrosonornicotine (NNN) are two of them.10  
Aromatic amines are products that include 4-aminobiphenyl 
(4-ABP) and 2-naphthylamine which were first recognized as 
bladder carcinogens due to exposure to various dyes10.  
The volatile hydrocarbons are 1,3-butadiene and benzene, a 
known  leukemogen. 1,3-butadiene and benzene are  potent 
carcinogens in cigarette smoke10.                      
Other carcinogens in cigarette smoke include vinyl chloride 
and ethylene oxide. Ethylene oxide is linked to lymphatic and 
hematopoietic malignancies. Cigarette also houses few metals like 
cadmium,polonium.10 
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URINE , BREATH AND BLOOD BIOMARKERS  
The carcinogens or their metabolites can be quantified by 
analyzing urine, breath, and blood. The products whose measurement 
is made   in urine are 
1. Trans, Anti-Phet and 1-HOP  for PAH11 
2. Total NNAL (NNAL plus NNAL glucuronides) for NNK  
3. MHBMA for 1,3-butadiene;  
4. tt-MA , S-PMA for benzene.  
Smokers show more amount of the products Benzene,  
1,3-butadiene in expired air. 
Benzene and styrene, are elevated when measured in the 
blood of smokers.   
Cotinine is a metabolite of nicotine. Cotinine assay is useful 
to estimate smoking in adults and smoke exposure in non smokers 
and children. 
Metabolism of various carcinogens of cigarette smoke 
The metabolic activation convert substances in cigarette 
smoke causing cancer to intermediate products. The products 
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interact with nucleophilic site in DNA, the ensuing product being 
DNA adducts. Detoxification reactions compete with metabolic 
activation. The DNA adducts   B[a]P-7,8-diol-9,10-epoxides 
(BPDEs)12 are potent mutagen which are produced following 
activation of B[a]P. The BPDE formation involves 
1. Metabolism of B[a]P to B[a] P-7,8-epoxide. 
2. Hydration of B[a]P-7,8-epoxide resulting in dihydrodiol B[a]P-
7,8-diol. 
3. More epoxidation to form BPDE. 
One enantiomer reacts with DNA to form adducts at N2 of 
deoxyguanosine and found to be highly carcinogenic. 
Detoxification pathways compete with B[a]P metabolic 
activation  by forming phenols through direct hydroxylation  of  
epoxides and Dihydrodiols  by hydration of epoxides  formation of 
glutathione, glucuronide, and sulfate conjugates.. 
An Unstable α-hydroxymethyl metabolite forms on activation 
of NDMA by α-hydroxylation. Methanediazohydroxide  is a 
product  obtained  when this unstable compound loses 
formaldehyde. It is also one of the products of NNK. Denitrosation 
is the way detoxification is carried out with production of nitrite 
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and methylamine. The protein forms cross-links and other products 
as it interacts with formaldehyde, an aldehyde produced by NNK.13 
α-hydroxylation of NNN  produces an intermediate which 
leads to pyridyloxobutyl (POB)-DNA adducts. Denitrosation 
produces norcotinine which is the way NNN is detoxified13. 
 7-(2-hydroxyethyl) guanine is a product as ethylene oxide 
interacts with DNA.  Glutathione conjugation and excretion of 
mercapturic acids is the pathway for detoxification. 
Benzene and 1,3-butadiene undergo activation during their 
metabolism 
Benzene is converted to benzene epoxide, on interaction with 
DNA produces 7-phenylguanine13.   
Metabolism of 1, 3-butadiene is through epoxidation  and 
form  monoepoxide that  further changes to  products, which  
results in DNA adduct formation.  Important among these are 
dihydrodiol epoxide which results in cross-links in DNA13. 
Enzy mes  in Carcinogen Metabolism 
Enzymes are essential in the activation and detoxification of 
carcinogens in cigarette. Few of them are P-450s, N-acetyl-
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transferases (NATs), epoxide hydrolases, and sulfotransferases 
GSTs, UGTs.  Their involvement in the metabolism of a carcinogen 
depends on properties of carcinogen properties like lipophilicity, 
size, polarity and of the property of enzymes which are regulation 
of expression structure and tissue distribution.   
Cytochrome P-450 Enzymes Cytochrome P-450 Enzymes 
P-450s are microsomal enzymes which involve  oxidation of  
carcinogens. The enzymes P-450s 1A1 and 1B1 are the ones which 
catalyse the metabolism of   PAH. Aromatic amines are processed 
with the help of the enzyme P-450 1A2. 
 P-450s 2A6, 2A13 and 2E1 are involved in the sequence of 
events leading to formation of metabolites from N-nitrosamines 14. 
P-450 2E1 is the key enzyme in the process of metabolisation of 
benzene and 1,3-butadiene which involves the  process of 
epoxidation. P-450 1A2 is the catalyst for aromatic amine N-
oxidation. Smoking induces and increases the levels of this enzyme 
in the liver. .  
Glutathione-S-Transferases(GST) 
The detoxification of   epoxides which exhibit carcinogenic 
potential ,is conjugation with glutathione. The cytosolic GSTs are 
the enzymes involved as the catalysts of glutathione conjugation of 
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the carcinogens. These four GST classes to which the enzyme 
belong are: alpha (GSTA1-1), mu (GSTM1-1), pi (GSTP1-1), and 
theta (GSTT1-1)15.  
GSTM1-1 and GSTT1-1 are vital for the metabolism of  two 
1,3-butadiene epoxide metabolites which involves conjugation. The 
two metabolites mentioned are 3,4-epoxybutene (EB) and 
diepoxybutane. The glutathione conjugation of benzene oxide produces 
S –PMA. This is the way by which benzene is detoxified and 
excreted in urine. GSTM1-1 or GSTT1-1 are involved in the 
conjugation of benzene oxide . 
Ethylene oxide is detoxified by glutathione conjugation. 
GSTT1 acting as a catalyst of this reaction in smokers expressed 
increased level of 2-hydroxyethylvaline Hb adducts. The carcinogens 
involved are ethylene and ethylene oxide in cigarette smoke. 
 Uridine-5′-Diphosphate-Glucuronosyltransferases 
Various carcinogens undergo metabolisation by conjugation 
with glucoronic acid. The microsomal enzyme Uridine- 5-diphosphate 
- glucoronyl transferases are part of the process. They are divided 
into two groups (UGT1 and UGT2). The diol and Phenol 
metabolites of PAHs are converted to glucuronide conjugates and 
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later eliminated. The excretion of the NNN is done after 
conjugation involving UGT. Detoxification of benzene is by 
conversion into products formed after conjugation with glucoronic 
acid.13 
Acetyltransferases 
Aromatic amines undergo N-acetylation ,which is the process 
by which they are eliminated. N-hydroxy metabolites of arylamines 
generated by P-450 (e.g., N-hydroxy-4-ABP), goes through a 
process of O-acetylation is activates them  and forms DNA Adducts13 
DNA Adducts and Biomarkers 
HPLC, liquid chromatography, electrochemical detection, 
32P-postlabeling and immunoassay are various methods to analyze 
DNA adducts.  
 Adducts and sources are 
1. 1.7-methyldeoxyguanosine - NDMA, NNK,  
2. O6-ethyl-deoxyguanosine and O4-ethylthymidine- ethylating 
agent (chemically uncharacterized). 
3. pyridyloxobutylate DNA-NNK and NNN 
4. 7-(2-hydroxyethyl) deoxyguanosine –Ethylene oxide 
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5. N6-ethenodeoxy-adenosine, 3, N4-ethenodeoxycytidine -  
vinyl chloride , ethyl carbamate. 
Some studies document clear evidence for elevated levels of 
adducts resulting from exposure to specific carcinogens such as 
B[a]P, NNK, or NNN16. .  
Carcinogen-albumin and carcinogen-Hb adducts are used to 
indirectly estimate DNA adducts. Advantages of Hb adducts as 
surrogates  are easy accessibility of  Hb in blood and the lifespan of 
red blood cells allowing adequate time to cumulatively aggregate in 
sufficient quantities for detection.16 
The Hb adducts of aromatic amines are biomarkers acting as a 
good source of information on the effects of smoking. Levels of 
these adducts are higher in smokers than in nonsmokers, 
particularly for 3-ABP–Hb and 4-ABP–Hb adducts. Adduct levels 
show a reduction on cessation of smoking and are related to the 
number of cigarettes smoked.  The amino terminal valine of Hb is 
the site where adducts attach and provide useful information 
.Smokers show increased Ethylated N-terminal valine of HB on 
comparison with nonsmokers. 
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Smokers show higher DNA adducts. DNA adducts are 
classified into  
1. Nonspecific adducts-detected by immunoassay and 32  
P-postlabeling  
2. Specific adducts, which are detected by structure-
specific methods. .  
Measuring levels of Hb adducts is very simple way to assess 
carcinogen exposure of the cell.   Accumulation of DNA adducts 
leads to genetic damage. The propagation of this genetic damage 
during clonal outgrowth is consistent with the accumulation of 
multiple genetic changes observed in cancer progression. 
Conversion of DNA Adducts to Mutations 
DNA replication has an vital role to play in producing point 
mutations through insertions or deletions. DNA adducts are not by 
itself mutations .It can be deleted by   repair mechanisms present in 
DNA. The ability to serve as a template is hindered when there is a 
modification in the form of deletion or insertion of a base. 
Therefore, DNA synthesis slows down or is blocked at the site of 
the adducted template. 
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Gene promoter hyper methylation can result in  loss of gene 
transcription and gene function is silenced. In initial stages of 
tumor formation, P16 gene undergoes this process of hyper 
methylation. AGT promoter hyper methylation, affects TP53 gene 
and results in tumor proliferation.17 
Nicotine or NNK promotes rapid multiplication of cancer 
cells and new blood vessel formation.  Cell-surface receptors and 
further cytoplasmic kinase activation is carried out by carcinogens 
present in smoke Among them, the two most important ones are 
proteins in BCL-2 family 18and NF-κB. These components also play 
a role in suppressing apoptosis.   Genetic and epigenetic events can 
lead to cancer causation. Critical cellular pathways are involved in 
proliferation of these transformed cells.  
Genetic polymorphisms   
Genetic polymorphisms have a role to play in tobacco-related 
neoplasm. Cigarette smoking is definitely a major risk factor in the 
development of cancer at various sites. It is a fact that smokers 
develop cancer. It is also further noted that not all smokers turn into 
patients harboring malignancies. This variation has kindled interest 
in genetic polymorphisms and carcinogen-metabolizing enzymes. 
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Polymorphisms in phase I and II enzymes have been 
observed. Phase I enzyme result in oxidation of the carcinogen, 
while phase II enzymes convert the carcinogen into products which 
are easily excreted. These products are predominantly water 
soluble. The enzymes which are catalyst for this reaction are seen 
to play a role in the activation and detoxification of carcinogens. 
Studies of the autopsy shows polymorphisms of CYP1A1 and 
GSTM1 and a raised DNA adduct levels. It can lead to minor and 
major variations in the metabolic pathways .This can be assumed as 
the cause of variation in response to carcinogens in smokers. Many 
studies have extensively investigated whether variation in 
metabolizing carcinogens can lead to variation in lung cancer risk.19 
Cytochrome-P1A1 Gene (CYP1A1) 
Inter individual variations in the ability to activate 
carcinogens such as PAH through the CYP1A1 gene leads to 
differential carcinogenic effects. Studies say that there are two 
variant polymorphisms in the CYP1A1 gene. The first is a base 
change in intron 6, which results in a new MSPI restriction site. 
The other polymorphism is in exon 7, a base change  which results 
in change in amino acid .  
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Among patients with squamous cell carcinoma (SCC), the 
homozygous variant genotype was associated with an increased risk 
of developing lung cancer, especially in those with a lower 
cumulative dose of cigarette smoke. .  
Studies have also associated the ILE462VAL polymorphism of 
CYP1A1 with lung cancer risk in Japanese and Chinese 
populations.20 Again, the homozygous variant *VAL/*VAL genotype 
was associated with lung cancer at lower cumulative doses of 
cigarette smoke.  The effects of genetic variability and differential 
enzymatic activity are more apparent at low doses, when saturation 
has not been reached. 
A study of African Americans and Mexican Americans 
showed a twofold increase in the risk of lung cancer among light 
smokers with the MSPI variant genotype. However, a Brazilian 
study showed an increase in risk with the *ILE/*VAL polymorphism 
but not with the MSPI polymorphism.  
Researchers found an association in Whites between the 
CYP1A1 homozygous *MSPI variant and lung cancer risk after 
adjustment of values for age and gender.   
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CytochromeP2E1 Gene (CP2E1) 
The CYP2E1 gene plays a role in the activation of NDMA, as 
well as other carcinogens. Le Marchand and colleagues made case-
control study with 341 lung cancer cases and 456 controls. These 
researchers found that CYP2E1 polymorphisms were associated 
with a decrease in risk of lung adenocarcinoma. A Chinese study 
confirmed this finding. However, the presence of at least one 
variant CYP1A1 *MSPI allele was associated with an increased risk 
of SCC. Associations between CYP1A1 and CYP2E1 polymorphisms 
and subsets of lung cancer indicate PAHs induce SCC and 
nitrosamines induce adenocarcinomas.21 
CytochromeP2A13 Gene (CYP2A13)  
The CYP2A13 gene plays a role  in the metabolic activation 
of N-nitrosamines such as NNK. Researchers have identified a 
polymorphism in CYP2A13 in which a amino acid substitution is 
seen at position 257. The variant 257CYS protein, the product of 
this gene, has one-third the capacity of the 257ARG protein to 
activate NNK. In a study of 724 lung cancer patients and 791 
control Observed that this variant of CYP2A13 genotype was 
correlated with a lower risk for lung cancer, adenocarcinomas in 
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specific. The reduction in risk did not reach statistical significance 
for SCC or other histologies of lung cancer22. 
Gluthatione S-TransferaseM1 Gene (GSTM1)  
Large variations in enzymatic activity for several GSTs are 
seen. The GSTM1 enzyme is important in detoxifying carcinogens. 
Some studies have found a link between the GSTM1 null 
mutation and lung cancer across many populations. In a study in 
Japan, the GSTM1 null genotype positively correlated with 
Squamous Cell Carcinoma of the lung, not with adenocarcinomas. 
An analysis in a Finnish population also associated the GSTM1 null 
genotype with SCC.  A U.S. study claimed that GSTM1 null 
genotype association showed modest elevation in lung cancer risk, 
which increased among heavy smokers.23 With stratification by the 
amount of smoking, the proportion of GSTM1 null genotype 
increased progressively in the SCC group from 50 percent in light 
smokers to 72 percent in heavy smokers. One study made a 
conclusion that higher intakes of cruciferous vegetables reduced 
lung cancer risk among persons with the GSTM1 genotype. 
However, several other studies have shown a greater protective 
effect in persons with the GSTM1 null genotype who consumed 
cruciferous vegetables 24. 
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The effect of GSTM1   appears to be increased by gene-
environment and gene-diet interactions. The high frequency of 
GSTM1 polymorphisms observed across all ethnicities may 
contribute to the importance of this variant as a risk factor for 
developing lung cancer. 
CYP1A1 and GSTM1 in Combination 
Studies of the effect of combined CYP1A1 and GSTM1 
variant genotypes hypothesized that increased PAH activation and 
decreased PAH detoxification in tobacco smokers might lead to an 
increase in lung cancer risk. Numerous studies have explored this 
association.  
Combination of the CYP1A1 variant genotype and the GSTM1 
null genotype enhanced the risk of smoking-related lung cancers in 
a Japanese population. Hayashi and colleagues (1992). They found 
a raise in frequency of the homozygous *VAL/*VAL genotype 
combined with the GSTM1 null genotype in lung cancer patients . 
The cigarette dose is low then CYP1A1 and GSTM1 may be an 
important determinant of susceptibility to  cancer 25 
Persons with these variant genotypes in both CYP1A1 and 
GSTM1 had a much higher risk of lung cancer than did those with 
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the variant CYP1A1 and wild-type GSTM1 . Studies in 
Scandinavian populations ,see an increase in the risk of lung cancer 
with the combination of variant CYP1A1 and GSTM1 genotypes.  
Gluthatione S-Transferase P1 Gene (GSTP1) 
 Polymorphisms in the GSTP1 gene is associated with family 
of phase II enzyme. One GSTP1 polymorphism includes an base 
change that leads to an isoleucine→valine substitution, which 
results in lower enzymatic activity toward 1-chloro-2,4-
dinitrobenzene  but higher activity toward PAH diol epoxides. In 
the largest study   with 1,042 cases and 1,161 controls, the GSTP1 
homozygous variant genotype was associated with a higher lung 
cancer risk at any level of exposure to smoke than was the wild-
type genotype.26 
In a study of 1,694 cases and 1,694 controls, double variants 
in GSTM1 and GSTP1, as well as in GSTP1 and TP53, were 
associated with an increase in lung cancer.  
Gluthatione S-Transferase T1 Gene (GSTT1) 
In a study of Chinese living in Hong Kong, the GSTT1 null 
genotype was associated with a higher risk of lung cancer than was 
the functional GSTT1 genotype only in non-smokers. A study from 
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Denmark also suggested that the GSTT1 null genotype is associated 
with a higher risk of lung cancer.27 
N-Acetyl Transferase 2 Gene (NAT2) 
Polymorphisms of the NAT2 gene are linked with decreased 
activity or reduced stability of the enzyme. The polymorphisms 
result in slow or fast acetylation. Most studies report no overall 
increase in risk with the genotype for either slow or fast 
acetylation. A study involving 1,115 lung cancer patients and 1,250 
control participants, NAT2 genotype and lung cancer risk exhibited 
no association. It showed significant interaction with smoking. 
Among nonsmokers, the genotype for rapid acetylation decreased 
lung cancer risk more than slow acetylation. In smokers persons 
with the genotype for rapid acetylation had a higher risk. A 
research from Taiwan said that the NAT2 genotype for fast 
acetylation is associated with an increased risk of lung cancer 
among women who were never smokers. 
The NAT2 protein is involved in bio-activation and 
detoxification of the aromatic amines associated with cigarette 
smoke.  
The risk of cancer was raised in smokers and higher chances 
among them were for persons with slow acetylation. 
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The NAT2 genotype for slow acetylation is associated with an 
increased risk of bladder cancer, cigarette smoking and 
occupational exposure to aromatic amines showing cumulative 
effects28.  
Microsomal Epoxide Hydrolase (MEH) 
MEH acts as an activator and a detoxifier of carcinogens. 
MEH is the enzyme which hydrolyses epoxide intermediate agents 
and converts them to less reactive dihydrodiols which is eliminated.  
MEH metabolizes PAH epoxides and activates them. Several 
identified polymorphisms include a base change in exon 3 leading 
to an amino substitution at residue 113, which involves a decrease 
in enzymatic activity. A base change in exon 4, which involves 
substitution at residue 139, which shows increase in enzymatic 
activity30.  There is a positive correlation between polymorphism 
causing an increase in enzymatic activity and risk of developing 
lung cancer. A study found this to be true with young Mexican 
Americans having exon 4 polymorphism, had an increased risk.. 
The presence of exon 4 and exon 3 polymorphisms, exhibited high 
enzymatic activity and also an increased risk . In a study in Taiwan, 
high MEH activity, recognized by combination of exon 3 and exon 
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4 polymorphisms, was associated with an increased risk for SCC 
(Lin et al. 2000). 
In nonsmokers, MEH activity is inversely proportional to 
cancer risk. It is due to inability to counter the effect of 
environmental pollutants by MEH when in low doses. The 
adenocarcinomas of the lung has better prognosis if exon3 
polymorphism is present. This shows Exon3 polymorphism has a 
protective role to play. 
CONCLUSIONS  ON THE MECHANISM  OF 
CARCINOGENESIS IN SMOKERS 
1. The doses of cigarette smoke carcinogens are indicated by the 
level of metabolites in Blood, Urine.  
2.  DNA adducts are formed by the  carcinogens which undergo 
metabolic activation which is induced by CYP-450  
3. In smokers, carcinogens can cause numerous changes at 
cellular level, which is caused by direct effect of these 
products. 
4. Cigarette smoke carcinogens can lead to mutations in TP53 
and KRAS . 
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5.  Smoking is associated with    methylation of genes like P16, 
which are tumor suppressors in lung cancer and other cancers  
The smoke constituents such as nicotine and 4-(methylnitrosamino) 
-1-(3-pyridyl)-1-butanone permit the survival of damaged 
cells. It is carried out by means of activation of signal 
transduction pathways.  
6. Smoking cessation is the only means of achieving  the  target of  
stopping the progress of pathogenic processes leading to cancer  
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ANATOMY OF ORAL CAVITY  
 Oral cavity is defined as the region from vermilion junction 
of the lips to the line of the circumvallate papillae of the tongue 
below and junction of the hard and soft palate above (Fig. 1). It can 
be divided into eight areas: 
1. Lip mucosa                5.Retromolar gingival (RMT) 
2. Buccal mucosa  6.Floor of mouth (FOM) 
3. Lower alveolar ridge  7.Hard palate 
4. Upper alveolar ridge   8. Anterior two-thirds of tongue(the OT)  
 
FIG-1           ANATOMY OF THE ORAL CAVITY 
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 EXAMINATION OF THE ORAL CAVITY 
      A simple clinical examination of the oral cavity is useful 
in identifying few premalignant and malignant lesion .Studies say 
that changes in buccal cells offers promise as biomarkers for early 
detection of  oral cancer. 
The investigations can be classified as in vivo and ex-vivo 
The in vivo tests differentiates normal, precancerous and 
cancerous epithelial cells.It is done using novel imaging techniques 
like fluorescence spectroscopy30,photodynamic imaging  of tumors 
that have incorporated  photofrin31 .The other in vivo test is to 
identify high risk premalignant lesion using toluidine blue32. It has 
been used successfully in clinical studies which correlated with 
histological progression. 
Ex-vivo tests include biopsies of normal and malignant 
tissues, scraping containing exfoliated buccal cells have been in 
vogue for quiet sometime33. Tests to identify buccal cell changes 
will be adjunct to clinical examination of oral cavity of subjects.   
HISTORY  OF EVOLUTION OF ORAL CYTOLOGY 
The   Papanicolaou and Traut studied the cells from cervical 
mucosa for precancerous and cancerous lesion paved way for oral 
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cytology. This work proved an effective tool for screening 
malignant disease of the cervix 34 .In the initial stages, comparative 
studies of oral and cervical cytology was done .They observed  
cellular changes based  on the phase of menstrual cycle.  
In late nineteenth century, sputum yielded malignant cells 
indicative of oropharyngeal carcinoma35. The diagnosis of 
nasopharyngeal carcinoma was done by using papanicolou staining 
in oral smears.  .  Cytology of the oral cavity was considered useful 
by many researchers. Later, Sandler, by his major work named 
Veterans Administration studies of oral cytology, opined that this 
technique   helps in early detection of oral malignancies37. 
Important events in oral exfoliative cytology 
1860 - Beale  - sputum in a case of pharyngeal 
carcinoma showed malignant cells 
1940  - Weinmann  - Cytological examination of oral 
cellular keratinisation 
1941 - Ziskin et al.  - Effects of the menstrual cycle on 
oral cellular morphology 
1942 - Papanicolaou - Introduction of a staining procedure 
for cytological smears 
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1943  - Papanicolaou  
and Traut - Cytological diagnosis of uterine  
  cancer 
1949 - Morrison et al. - Cytological diagnosis of 
nasopharyngeal malignancies  
More recent advances in oral cytology are 
Meyer, Rubinstein and Medak (1970)34  
Mucosa of the smokers and non-smokers was compared. In 
both the groups, subjects had clinically healthy mucosa and they 
found early response to smoking is in the form of change to less 
keratinized cells. Meyer et al suggested that exfoliative cytology in 
smokers is a useful investigation to identify alteration in apparently 
normal buccal mucosa. 
Bernstein and Miller (1978)35  
They stated oral exfoliative cytology, if properly used could 
be a tool for the early identification of premalignant and malignant 
lesions. Advantages of the cytology techniques despite its pitfalls, 
is simple, painless, inexpensive and rapid 
Hillman and Kissin (1980) 36 
Studied exfoliative cytologic smears from the cheeks of 790 
alcoholics and evaluated the correlation between microscopic 
 33 
features and selected indicators of nutritional status and observed 
that a significant association existed between the cell/nucleus 
ratios. They observed that poor diet patterns caused an increase in 
nuclear size and reduction in cell/nucleus ratio.   
Cowpe JG and Longmore RB, (1981) 37 
Made a morphometric analysis on clinically normal buccal 
mucosal cells with parameters like nuclear area .There was no 
significant variation seen in the nuclear size.  
Van Molengraft et al (1982)38  
Observed that there was no significant difference in cellular 
and nuclear diameters between solitary and clustered cells.  
Scott J et al (1983)39  
They said a reduction in nucleus/cytoplasmic ratio with 
advancing age in the study on normal lingual epithelium. 
Cowpe et al (1984)40 
They used quantitative techniques to assess the exfoliative 
cytology smear from normal and abnormal human oral mucosal.   
The study noticed that the malignant lesions exhibited abnormal 
DNA distribution histograms and the cytomorphological values 
displayed significant variation, when compared with the normal 
squames. 
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 Cowpe JG and Semmens HE, (1985) 41 
Nuclear and cell size of normal buccal squamous cells are un 
affected by menstrual cycle. It came to a conclusion that oral 
smears do not demonstrate the time of ovulation or stage of 
menstrual cycle  
Burkhardt et al (1985) 42  
The success in exfoliative cytology in early detection of 
cervical cancer has motivated numerous studies on oral mucosa. 
But unlike the uterine cervix, metaplasia does not occur in the oral 
cavity. It is also observed that only superficial cells are recovered 
which gives little information about the deeper layers and makes its 
value very restricted in the oral cavity.  
Cowpe, Longmore and Green (1985) 43 
Oral smears were obtained from various sites of the oral 
cavity, of different age groups and of both sexes. There was 
significant variation in cytoplasmic area, nuclear area and at 
different sites .The nuclear size varied significantly with increasing 
age. It also stated there were no differences between males and 
females. 
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Smeulders and Dorst (1985) 44 
A sharp definition of the objects to be measured or not to be 
measured using strict qualitative criteria is therefore essential. The 
poor quality of slide preparation can cause difficulty in identifying 
the objects to be measured. Moreover, poor fixation resulting in 
ballooning and vague outlines and under staining or over staining 
hinders the segmentation (discrimination between foreground and 
background). Optimizing staining techniques and the quality of 
slides is of major importance in quantitative cytopathology.  
Abdel Salam et al (1986) 45 
Studied   the utility of image analysis in distinguishing among 
oral white lesions. They observed that image cytometry is a 
upcoming field of research for oral disease. The analysis of 
morphology of cells and nuclear parameter is useful in 
understanding behaviour of the disease. 
Hill and Gibson (1987) 46 
 Their study was on the oral and dental effects of Qat chewing 
in 121 volunteers and found that the buccal mucosa in 50% of the 
subjects was normal and in the remaining subjects some degree of 
keratosis was found and none showed any evidence of malignancy 
or dysplasia  
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Creath, Shelton and Wright (1988)  48  
Studied the prevalence of use of smokeless tobacco by 
adolescent athletes. The associated abnormal mucosal findings were 
noted. They observed that oral leukoplakia is more common in 
those who had dipped smokeless tobacco for more than 2 years 
would have a high incidence of oral leukoplakia.  
 Cowpe, Longmore and Green (1988)49 
Applied quantitative techniques to the smears collected from 
the abnormal buccal mucosa and floor of the mouth, which were 
compared with normal smears. In their study, statistically 
significant variations were observed in nuclear and cytoplasmic 
areas .The abnormal smears showed an increase in the nuclear area 
and a reduction in cytoplasmic area.  The result displays a good 
success rate for identifying premalignant and malignant lesions 
.The quantitation provides an excellent investigation to detect early 
oral malignancy.  
Chen S.Y. (1989 ) 50 
Experiments on male & female rats in which their buccal 
mucosa was subjected to   application of tobacco on the buccal 
mucosa for 1 year. It established that the tobacco treatment can 
disturb the mitotic process  
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Bramlye and Smith (1990) 51 
There are methods other than biopsy such as exfoliative 
cytology for sampling oral cancer. They stated that it is a very 
simple procedure. The disadvantage is many false negative results, 
mainly of the precancerous lesions of oral mucosa.  
Ogden, Cowpe and Green (1990) 52   
 The study made an effort to use semi-automated image 
analysis techniques on smears obtained from normal oral mucosa 
.The regions which were suspected of being dysplastic were 
assessed for the cytomorphologic features and DNA content of 
buccal mucosal cells .It was found that smears with malignancy had 
a significant reduction in cell area, in comparison with normal 
subjects  
Gao S et al, (1995) 53  
The study attempted a Morphometric analysis on the spinous 
cell of oral sub mucous fibrosis and compared it with normal oral 
mucosa, leukoplakia, dysplasia and carcinoma. Surface area, 
perimeters, and all kind of diameters of the cells showed a 
progressive decrease from normal mucosa through dysplasia to 
carcinoma. The nuclear cytoplasmic ratio showed a progressive 
increase. The dimensions of nuclei did not show any significant 
differences.  
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Sugerman P.B. and Savage N. W (1996) 54 
They said oral cytology is a non-invasive procedure to assess 
changes in oral epithelium and its utility is in the screening for 
dysplasia and carcinoma. They concluded that exfoliative cytology 
is possible in patients abusing tobacco in the form of betel quid, 
who can develop oral malignancies. The smears from premalignant 
and malignant lesions exhibited a raised nuclear cytoplasmic ratio,   
increased keratinization, and pleomorphism of the nucleus. 
Gray T, Bancroft J D, Stevens A (1996) 90 
Cytomorphology of oral cavity made significant progress 
with digital image analysis. Digital image processing systems use 
images held in a computer’s memory. This allows the computer to 
look at an image correctly and opens the possibility of fully 
automatic analysis of the image by a computer programme. The 
digital video image is divided into an array of small rectangles, 
called pixels and their appropriate brightness value is stored in the 
computer’s memory. Multiple objects, consisting of groups of 
numerous pixels, can be automatically selected and measured if the 
brightness value is sufficiently different from the surrounding 
background. The process normally involves the production of the 
temporary coloured binary image that is areas to be measured are 
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coloured red while the rest are coloured blue. This is superimposed 
over the digitized image so that the operator can check which 
objects are to be measured. This can be fixed so that automatic 
measuring is possible. To display the digital image, each pixel’s 
memory location is read and redisplayed on the monitor.  
Colour selection is performed by defining the unique ratio of 
red, green and blue for a specific colour, which can be re-expressed 
as its hue, saturation and intensity (HIS).   
T.Ramesh et al (1998) 55  
They studied the changes in morphology based on cell 
diameters and nuclear diameter of squamous cells of oral 
premalignant and malignant lesions. They suggested that nuclear 
diameter and Cell Diameter could be utilised in the investigations 
to identify oral lesions which are premalignant and malignant.  
Ogden, Wright and Rice (1999)  56  
The study analysed the ways alcohol affects quantitative 
cytomorphometry on the oral mucosa. There was reduction in the 
mean nuclear area and mean cytoplasmic area in alcohol group. 
This could be due to dehydrating action of alcohol on the cells. 
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 Heloisa de Castro Sampaio et al (1999) 57  
Compared the AgNOR count of cells collected from normal 
buccal mucosa of cigarette smokers with that obtained from non-
smokers. Cytological smears of normal buccal mucosa from 20 
smokers and 20 non-smokers were stained for AgNORs. The 
AgNOR count was established in 100 cells. The mean AgNOR 
count was higher in cells of smokers than non-smokers.  
Amit Chattopadhyay et al (2002) 58 
Silver stainable nucleolar organizer regions (AgNORs), as 
proliferative marker may play a role in identifying dysplasia in 
tissue specimens. Mean AgNOR  is a good parameter for defining 
objective parameters  in dysplasia  
Cytology Techniques and  Modifications  
Over years, as oral cytology grew, many investigators 
experienced the limitations of oral cytology and felt the need for 
improvements. They introduced  many modifications which  procured 
larger amount of cells, to sample a large cellular area and  improve 
the quality of cell staining. Special stains have been advised, to 
identify the best area for cell collection in a diffuse lesion .The cells 
of the basal and Para basal layers can be visualized, if the atypical 
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keratotic cell layers are removed.Few advocated the use of a metal 
spatula or a sharp spoon for this procedure. 
Numerous analytical methods for light microscopy were used. 
The use of  fluorescence microscopy and phase contrast microscopy 
was explored. Fluorescent DNA-specific dyes like Acridine Orange 
measure the cellular DNA content . Cytomorphological parameters 
for malignancy, was done with the help of image cytometry.   
Besides these applications of the oral cytological studies, Epstein–
Barr virus  can be demonstrated in  hairy leukoplakia. Oral cells 
can be obtained from a sample of saliva,material from rinsing or by 
scrapping of the  mucosa 
The instrument for making a nice cytological smear must 
show the following features 
1. Must be at ease to use even at difficult sites in the mouth 
2. Traumatic damage must be very minimal 
3. Help in procuring adequate number of cells  
Brush biopsy is a simple, safe highly sensitive, relatively 
cheaper method of screening for cancer.  A full Trans epithelial 
cellular sample is procured with ease with the brush .The 
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combination of smears and image analysis system go a long way in 
recognizing oral epithelial abnormalities.  Pinpoint bleeding is 
evidence that a full thickness sample has been obtained. 
The introduction of the oral brush is important in the history 
of oral cytology. Use of a brush for cervical cytology demonstrated 
better cell spreading on objective slides as well as an improvement 
in quality and validity of smears compared with smears obtained by 
using a wooden spatula59. It is a more convenient instrument, than 
the wooden tongue depressor, in oral lesions. This technique is 
painless and easy investigation that can be used to assess any 
suspicious lesion. 
A study stressed the need for brush biopsy with automated 
imaging, where clinically benign-appearing mucosal lesions were 
sampled using this technique and 5% were later confirmed by 
biopsy to represent dysplastic epithelial changes or invasive cancer. 
Many others opined that brush cytology could discover lesions that 
were not clinically suspicious of carcinoma or pre-invasive disease   
.  A study clubbed conventional oral brush cytology and application 
of toluidine blue to identify the site for brushing in suspicious 
mucosal regions. Mehrotra et al.,in his study recently, impressed on 
the utility of automated analysis in minimally suspicious lesions. 
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Evolution  and Modifications in techniqes in oral exfoliative cytology- 
1951 - Gladstone - Improved quantities of obtained cells 
by use of a “sponge biopsy” 
1952  - Schneider  - Modifications of staining 
1960 - Cawson   - Modifications of staining 
1963 - King        - Use of frosted glass slides 
1963 - Staats and Goldsby - Comparison of wooden and metal 
spatula.Recommendation of the metal 
spatula 
1964  - Sandler - Removal of keratotic layers with a 
sharp Curette 
1981  - Dumbach et al. - Smear curettage’. Inclusion of deeper 
cell layers by use of a curette 
Few recent advances in methodology in oral exfoliative 
cytology are 
Ogden G R et al (1989)   
Assessed the effect of fixatives on morphological features in 
oral cytology. Three methods were employed. These included spray 
fixation,Direct immersion in ether and ethanol in equal proportions 
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and air drying. The observation was no difference found , whatever  
fixation method  used. 
Van Diest et al (1989) 61 
It investigated mechanical influences of the smear and of 
preparation techniques on cells and nuclei. Neither method led to an 
area dependent distribution (area gradient) of the cells or nuclei on 
the side of induced orientation of the cells or nuclei on the slide or 
induced orientation of the cells or nuclei. 
 Herzberg A J, Raso D S, Silver man J F ( 1999 )62 
In his color atlas of normal cytology, used number of 
techniques in the collection of oral epithelial cells for cytologic 
examination. Instrument like wooden tongue depressors, metal  
spatulas, and cotton tipped applicators were commonly used.                                          
Oral cytology is  vital in the early diagnosis of oral cancers, 
as a technique for obtaining cell samples that  is analysed  by 
sophisticated diagnostic techniques such as DNA cytometry, and 
molecular analyses and cytomorphometry. The   techniques like 
Toluidine blue staining, brush biopsy and sophisticated computer 
programs have changed the field of oral cytology. It has made 
interpretation of findings far more reliable. The cytological study of 
oral cavity is simple, non-aggressive and relatively painless, and 
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rapid. It is accepted by patients and suitable for application in 
population screening programmes, for early analysis of suspect 
lesions, and for pre-and post-treatment monitoring of confirmed 
malignant lesions.  
The oral cavity is squamous epithelial lining with difference 
in surface keratinization at various sites. 
SAMPLING METHODS OF THE ORAL CAVITY 
The mouth is sampled by smears obtained by scraping.  The 
scrape smears are obtained with a tongue depressor or a small 
curette. The lesions covered with thick layers of keratin, require a 
more vigorous scraping with a sharp metallic instrument . 
INDICATIONS FOR CYTOLOGIC EXAMINATION 
The application of cytologic techniques to the oral cavity is 
the diagnosis of occult carcinomas, not identified or not suspected 
on clinical inspection.  
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CYTOLOGY OF NORMAL ORAL SQUAMOUS 
EPITHELIUM  
Squamous Epithelial Cells 
Normal squamous epithelium of the oral cavity has 
superficial and intermediate squamous cells. They occur singly or 
in clusters and are identical with squamous cells that are found in 
specimens of sputum and of saliva . 
Condensation of the nuclear chromatin like a nuclear bar with 
lateral extensions,   has been recorded in superficial squamous cells 
by Wood et al (1975)63. These cells are seen in the mucosal surface 
of the adjacent floor of the mouth and the lower lip  in  healthy 
people . The change is probably related to “nuclear creases” . 
Similar cells may be observed in mesothelial cells in the 
pericardium, surface of the conjunctiva and in other organs.  
Superficial cells without  nuclei are known as keratinized 
squames, more common from the palate and are normal. All stages 
of transition between nonkeratinized and keratinized cells may be 
observed. Smaller para basal squamous cells are seen, if an 
ulceration is present or procedure is done vigorously. Squamous 
oral cells carry blood group on their membranes.64 
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Other Cells 
The nasopharynx and salivary gland duct produces columnar 
cells rich in mucin. Lymphocytes, singly or in clusters are seen, 
when base of tongue or tonsillar area is vigorously scraped.   
Oral Flora  
Entamoeba gingivalis is fairly common. People who have 
poor oral hygiene harbor many types of bacteria and saprophytic 
fungi. An unusual organism, Simonsiella species, was described by 
Greene Baum et al in smears of oropharynx, sputum, and gastric 
aspirates in 198865. The large bacteria form caterpillar-like chains, 
made of 10 to 12 individual bacteria. The bacterial chains are 
readily observed overlying squamous cells (Fig. 21-2B). The 
organism is nonpathogenic, is observed in mouths of people with 
rich dietary intake, particularly fat and proteins. 
Buccal Squamous Cells in Genetic Counseling and as a Source of DNA 
Buccal smears are the cheapest and easiest-to-use test to 
determine genetic sex, by observing and counting sex chromatin 
(Barr bodies) in squamous oral cells. The Barr bodies are half-
moon shaped chromatin condensation at the nuclear membrane. In 
genetic females all squamous cells with nonpyknotic, open 
vesicular nuclei should contain a Barr body.In reality, it can be 
 48 
identified in fewer than half of these cells by light microscopy of 
oral smears stained with Papanicolaou's stain.  Peripherally placed 
chromocenters and focal thickening of the nuclear membrane may 
mimic Barr bodies. Occasionally, malignant cells may contain two 
or more Barr bodies, reflecting aneuploidy.66 
The presence of Barr bodies in a phenotypic male strongly 
suggests Klinefelter's syndrome (47 chromosomes, YXX). The 
absence of Barr bodies in a phenotypic female suggests Turner's 
syndrome. 
Buccal cells collected by mouthwash or by other techniques 
acts as a source of DNA for various tests, including person 
identification. 
INFLAMMATORY DISORDERS 
The diffuse inflammatory processes and poor oral hygiene 
produces ulceration or erosions.  The large Para basal squamous 
cells come into picture than the superficial and intermediate cells 
which are normally seen. They exhibit is multiple, round or oval 
vesicular nuclei.   Small nucleoli and chromo centers are noted. The 
cytoplasm is often poorly preserved.  
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Multinucleated macrophages may occur in chronic 
inflammatory process. These conditions express purulent exudate 
and leukocytes. Plasma cells are also seen, more commonly with 
smears obtained from posterior pharynx 
SPECIFIC INFLAMMATORY DISORDERS 
Oral Herpes 
This common disorder, characterized by blisters and painful 
ulcerations, is caused by Herpes virus type 1. Kobayashi et al 
(1998) observed the pathognomonic cell changes in smears of only 
4 of 11 patients in whom the diagnosis could be confirmed by 
culture. 
Moniliasis (Thrush) 
Clinically, moniliasis forms a characteristic white coating of 
the oral cavity. This organism may be identified by finding the 
characteristic fungal spores and pseudohyphae. It occurs in 
diabetics, HIV patients. In HIV patients, it may be the first clinical 
symptom. 
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CHANGES IN ORAL SQUAMOUS CELLS IN DEFICIENCY 
DISEASES 
In deficiencies of vitamin B12 and folic acid, both the nucleus 
and the cytoplasm of the squamous cell show increase in size.  
Megaloblastic anemia, tropical sprue may show identical changes67.  
Vitamin B12 and folic acid are vital ingredients for DNA synthesis. 
If either one is inadequate, the DNA synthesis is altered, exhibiting 
cell enlargement.  
OTHER BENIGN DISORDERS 
Benign Leukoplakia 
Heavy keratin formation on the surface of epithelium is a 
process localized to areas like the palate, parts of gingiva. The 
benign leukoplakia is milky white appears histologically as a 
benign squamous epithelium, with layers of keratin. The 
precancerous leukoplakia may have a similar clinical appearance. 
Cytology of benign leukoplakia is  fully keratinized, yellow  
stained cells without nuclei being characteristic of this disorder68. It 
may also be seen in normal oral smears; therefore, the cytologic 
diagnosis should always be correlated with clinical findings. 
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MALIGNANT LESIONS 
Invasive Squamous Carcinoma and Its Precursors 
RISK FACTORS 
Abuse of alcohol and more importantly smoking are the key 
epidemiologic factors in patients developing malignancies of the 
mouth. Tobacco contains carcinogens which initiates and promotes 
cancers in the oral cavity. Tobacco in any form, such as pipe-, 
cigar-, or cigarette smoking, reverse smokers (people holding the 
burning end of a cigarette in their mouth), betel-nut chewers 
(tobacco powder is often wrapped inside the betel leaf) represent 
high-risk populations. The latter two forms of tobacco use are seen 
mainly in India and other parts of Southeast Asia. In America, 
African-Americans have a higher risk of oral squamous cancer than 
other people  (Skarsgard et al, 2000).  
Pure ethanol is never carcinogenic, but increased risk of 
upper aero digestive tract cancer is associated with alcohol drinking 
in non-smokers. Alcohol acts as a solvent, facilitating the package 
of carcinogens through cellular membranes which has a role in 
carcinogenesis.  
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Acetaldehyde produced by microflora by the oxidation of 
ethanol is responsible for alcohol associated carcinogenesis.  
Several studies have reported association between poor oral 
hygiene and oral cancer. Experimental evidence in animals show 
localization of chemical carcinogens induced tumors to the sites of 
repeated mucosal traumatization. 
Clinical observations in human cases describe carcinomas 
developing at sites of chronic trauma caused by a broken teeth or 
ill-fitting dentures. It is certain that the role of inflammation, due to 
poor oral hygiene, is seen in the pathogenesis of oral carcinoma. It 
is compounded by known carcinogens such as tobacco, alcohol 
abuse, nutritional deficiencies. 
Dietary deficiencies of Vitamin A, C, and E are associated 
with oral cancers.Trace elements such as zinc, selenium may 
contribute to development of oral cancer.A study in china found a 
strong protective effect of carotenoid, vit.c  and fiber intake  in oral 
cancer risk. 
An increased risk for oral cancers is HIV /AIDS population 
and immunosuppression in organ transplant recipient.The  
incidence of cancer of lowerlip is increased in both population 
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                              Human papillomavirus (HPV)  presence in 
oral cancer has been suspected for some years and has now been 
documented in lesions of the oral cavity69. Garelick and Taichman 
(1991) observed HPV types 2, 4, 6, 11, 13, and 32 in the benign 
lesions, including leukoplakia, and HPV types 16 and 18 in oral 
carcinomas. Paz et al (1997) observed HPV sequences in only 15% 
of squamous cancers of the esophagus and the head and neck area. 
HPV was mainly observed in tumors of the tonsillar area and in 
some metastases. The presence of HPV had no prognostic 
significance. Mork et al (2001) considered infection with HPV type 
16 as a risk factor in squamous cancer of the head and neck. 
Cytology 
The biopsy of clinically suspicious lesions yields a diagnosis 
of invasive squamous cell carcinoma. The ulcerated invasive 
lesions can be diagnosed cytologically.  It is necessary to remove 
necrotic material   before cytologic sampling.  The background 
always shows  blood,  numerous leukocytes and necrotic material. 
The degree of keratinization can be assessed by cytology. The 
cancer cells are large withorange- and yellow-staining cytoplasm.  
They also have pyknotic, dark-staining irregular nuclei. “Ghost” 
cells have no nuclear material. The mean AgNOR value of  a 
 54 
squamous cell carcinoma is the highest in comparision with benign 
and precursor lesions. The cytologic diagnosis  of nonulcerated, 
invasive, keratinizing carcinomas, like verrucous carcinoma , is not 
clear as abundant “ghost” cells hinder the observation of malignant 
cells. Reddy and Kameswari (1974) made a study with 165 patients 
with keratinizing carcinoma of the hard palate in reverse smokers in 
India and  diagnosis was made  in only 60% of the patients.70 
Similar results were reported by Bànóczy and Rigó (1976). A 
detailed observation of   nuclear abnormalities was made, which 
occurs in only a few cells. Irregularity of outline, nuclear 
hyperchromasia, nuclear enlargement, is of diagnostic significance.  
A biopsy is advised if diagnosis is suspicious. 
In poorly differentiated squamous carcinomas, keratinization 
is not prominent, ,  but coarse  chromatin  and nucleoli which is 
large is seen. In oral cancer,  nucleocytoplasmic ratio is usually 
modified in favor of the nucleus  
PRECURSOR LESIONS IN ORAL SQUAMOUS CELL  
CARCINOMA 
Identifying precursor lesions may be lifesaving in case of oral 
cancers. Precancerous lesions of the squamous epithelium of origin 
invariably precede invasive cancer. 
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Two types of precancerous lesions in the oral cavity: 
The common white lesions with irregular, jagged borders, 
usually referred to as precancerous leukoplakias,  similar to the 
benign leukoplakias, and correspond to precancerous lesions with a 
heavily keratinized surface and nuclear abnormalities in well-
differentiated squamous cells . The white color of the lesion is due 
to the opaque surface layer of keratinized epithelium. Mild or 
Moderate dysplasia is often attached to such lesions.71 
• The less common red lesions (erythroplakia), corresponding to the 
nonkeratinizing precursor epithelial lesions, are usually composed 
of smaller cancer cells with minimal or absent keratinization of 
surface (carcinomas in situ or severe dysplasia) 71. The red color is 
because of vascularized stroma underlying the often thin 
epithelium. The lesion is a precursor of invasive squamous cancer 
.It is recognized in  the studies by Sandler (1962, 1963), Shafer et 
al (1975), and Mashberg et al (1977). Niebel and Chomet (1964) 
suggested in vivo staining of the oral mucosa with toluidine blue to 
demarcate the territories of these lesions. 
•  Incidentally discovered, there are no visible oral lesions. 
Acetowhite areas, after application of 3% acetic acid solutions, 
may be observed in such patients. 
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It is difficult to diagnose precancerous leukoplakia and 
keratinising carcinoma in situ.The abnormal cells in smears are 
obscured by anucleated squames or keratinized benign cells.   Few 
visualized cells suggest either a borderline squamous lesion or a 
well-differentiated squamous cancer with keratinized cytoplasm 
and nuclear enlargement. In these conditions, it is of prime 
importance to note the clinical finding .The information from 
cytology may be minimal, is a indication to proceed for a biopsy 
Hong et al opined that a beneficial effect on the size and 
degree of cellular abnormalities in oral precancerous leukoplakias 
of some patients is seen with administration of 13-cis retinoic acid. 
Nonkeratinizing Lesions 
Oral carcinoma in situ or severe dysplasia, are not similar to 
precancerous leukoplakia. They are seen without significant keratin 
formation on their surfaces and have malignant epithelial cells.  All 
these lesions present clinically as areas of redness (erythroplakia) . 
Scrape smears from such lesions are characterized by the 
presence of both malignant parabasal and intermediate cells with 
marked nuclear enlargement, hyperchromasia with a translucent 
cytoplasm.  A few squamous cancer cells show marked nuclear 
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abnormalityand keratinized cytoplasm. The smear pattern in oral 
carcinoma in situ is remarkably similar to that of a high-grade 
squamous precursor lesion of carcinoma of the uterine cervix of 
well-differentiated type. 
Stahl et al (1964), observed the implications of dyskaryosis in 
oral mucosal lesions, pointed out the necessity of long-term follow-
up of patients showing such cells in their smears.  
RESULTS OF CYTOLOGIC SCREENING FOR OCCULT 
CARCINOMA AND PRECURSOR LESIONS 
The difficulty in clinical identification of precancerous 
leukoplakia and carcinoma in situ, both easily curable precursor 
stages of oral cancer, was appreciated in an extensive cytologic 
study of mouth lesions which was conducted by the Veterans 
Administration, guided by Dr. H. Sandler. There were 2,758 
patients with visible mouth lesions identified by cytology, and there 
were 287 histologically documented cases of invasive carcinoma. 
Many of these lesions were very small, many were not ulcerated, 
not indurated, and not fixed to the underlying tissue.  
There were 28 patients with carcinoma in situ.  Thirteen 
lesions were reddish in color, 6 were white, and the rest were of 
various colors; only 6 were ulcerated and only 5 indurated.  
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Redness of circumscribed areas of oral epithelium, erythroplakia is 
frequently characteristic of carcinoma in situ. 
•
 Shafer studied the clinical and histologic data on 82 oral 
carcinomas in situ diagnosed by biopsy only. The comparison of 
clinical findings of both the studies  showed roughly 50%of 
Sandler's lesions were red, whereas there were only 16% of such 
lesions in Shafer's survey,  suggesting that even competent 
observers consider red oral lesions as benign and do not  biopsy 
them. Such lesions should be the prime target for cytologic 
screening.72 
A survey by Stahl et al (1967) confirmed that cytologic 
screening for oral cancer is feasible.   It does not appear feasible or 
reasonable to cytologically screen all dental patients.  A scrape 
smear of an oral lesion may well permit more conservative surgery 
for earlier lesions and may be life saving.AgNOR count in 
precursor lesion is on the higher side in comparison with benign 
lesions. Shiboski et al (2000) recently made an observation of 
deficiency in the education of professional and public education for 
early diagnosis of oral cancer. 
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Sandler's, Shafer's, and Mashberg and Meyer's studies pointed 
out that the floor of the mouth was the most frequently affected site 
of oral squamous cancer, followed by lateral surface of tongue and 
soft palate. These  areas  deserve a careful inspection during routine 
dental examination. 
Within recent years, there has been a revival of interest in 
cytologic detection of oral cancers based on evaluation of oral 
smears by a semi automated cell analysis system OralCDx 
(Sciubba, 1999). A specially designed brush was used to secure cell 
samples from the visible lesions of the oral cavity. Of the 945 
lesions sampled by cytology, 131  were “dysplastic” lesions or 
carcinomas confirmed by biopsies. In these cases, the smears were 
judged to be either “positive” or “atypical” .  
Extensive surveys are necessary,in which increased risk of 
oral cancer exists.  One such study by Wahi, impressed upon the 
value of cytologic techniques among betel-nut chewers. The table 
gives details of the study.The data strongly suggest that high-risk 
candidates for oral cancer are primary target for screening   by 
cytologic techniques for oral malignancies. 
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TABLE 1 CYTOLOGIC DIAGNOSIS OF ORAL 
CARCINOMA AMONG BETEL-NUT CHEWERS 
Total cases of oral cancer studied 812 
Clinically unsuspected 
(66 squamous carcinoma, 2 reticulum cell sarcoma, 1 
adenocarcinoma) 
69 
Clinical diagnoses on 69 unsuspected cases  
Leukoplakia 26 
Ulceration 27 
Trismus 9 
Dysphagia 4 
Tonsillar enlargement 3 
Cytologic diagnoses on the same cases  
Malignant cells 39 
Cells suggestive of cancer 21 
Dyskaryotic cells, possibly Malignant 
(Prof. P.N. Wahi, Agra, India, personal communication.) 
9 
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CYTOLOGIC DIAGNOSIS OF RECURRENT ORAL CANCER 
AFTER TREATMENT 
• A close follow-up of all patients is essential when local 
recurrences after treatment is possible. The have an increased 
chance of treated patients to have a second malignancy or a 
recurrence.  The addition of cytologic techniques with the 
follow-up examination may result in the diagnosis of a recurrent 
or new cancer ,before it is suspected clinically.73 
• Hutter and Gerold (1966) used cytologic techniques in the 
follow-up of patients previously treated by surgery.  The 
application of cytology to the patients without visible lesions, 
uncovered clinically unsuspected recurrent cancer in 10 of 177 
patients investigated. They used material scraped from the 
general area of prior surgery by an endometrial curette.  
• This work, as well as the results of cancer detection surveys 
described above, strongly suggest that the silent stage of 
carcinoma in situ, whether primary or recurrent, is not readily 
identifiable clinically and precedes invasive squamous carcinoma 
of the oral cavity. This stage of cancer may last for several months, 
and possibly much longer, before producing a visible lesion. 
Carcinoma in situ may be accurately identifiable by cytology. 
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AGNOR 
Human beings have 23 pairs of chromosomes, 22 pairs of 
autosomes and 1 pair of sex chromosome. Based on location of 
centromere they are classified as 
1. Metacentric  
2. Sub metacentric 
3. Acrocentric 
The acrocentric chromosomes are 13, 14, 15, 21, and 22. 
A satellite chromosome is which shows a secondary 
constriction with chromatic knobs extending from the arms on  
stalks which are slender .It may also present with negative hetero 
pyknosis at the ends of chromosome arms.79 
All the acrocentric chromosomes, showed satellites on their 
short arms which were associated with nucleolus in the prophase 
cells. They are loops of DNA involved in transcription of ribosomal 
RNA (rRNA) genes. It functions in the organization of nucleoli. It 
is therefore called as nucleolar organizer regions.75 
Nucleoli are organized at specific regions of specific 
chromosomes and are best seen at prophase. In this stage, two parts 
 63 
of the chromosomes appear at diametrically opposite sides of the 
nucleolus. 
In metaphase nucleolus organizer section become very thin, 
stain poorly, known as secondary constriction. The second 
constriction may serve as identifying landmark for specific 
chromosomes. 
Acrocentric chromosome approach each other with their 
satellite more often than randomly expected.  Cytogeneticists, 
started investigating this preferential satellite associations as a 
cause of chromosomal non disjunctions   
 
FIGURE 2: ORGANIZATION OF A TYPICAL NUCLEOLAR 
ORGANIZER REGION75 
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PHYSIOLOGY OF AGNOR’S AND CELLULAR KINETICS: 
Ultra structure of the human nucleoli shows three 
substructures76. 
These are composed of 
a) The dense fibrillar component – packed electron dense 
fibrils. 
b) The fibrillar center – composed of loose network of fibrils. 
c) The granular component. 
The dense fibrillar component has lightly packed electron 
dense 3-5nm thick fibrils and is the site for processing of ribosomal 
RNA precursors.  
The fibrillar center is the site for the production of ribosomal 
RNA and it composes topoisomerase I, RNA polymerase I and 
ribosomal DNA.  
The precursor of ribosomes constitutes the granular component. 
The behaviour of the tumour may be assessed by determining 
the proliferation rate. The cell cycle is divided into four phases 
based on the nuclear chromatin activity. They are S, G1, G2 and G0 
phases. There is a short resting phase of the cell undergoing 
replication at the ‘S’ phase. Thus, the DNA content at the end of 
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‘S’ phase is an indicator of proliferative activity and AgNOR 
detects the DNA content at this stage. 
The size, shape and number of the NORs changes according 
to nucleolar transcription and are related to the cell cycle. Since 
nucleolar transcription rate and cell turnover is comparatively high 
in proliferating cells, assessment of the morphology and quantity of 
NORs helps in assessing cell proliferation 
DEMONSTRATION OF AgNORS: 
The NORs can be visualised by various techniques which 
either demonstrate NOR associated proteins or the ribosomal DNA 
itself 
 DEMONSTRATION OF NORs 
 Reagent                             Target 
Silver colloid (AgNOR)   NORAPs 
Bismuth ions                      100K NORAP 
Radiolabelled rRNA             rDNA 
Antibodies                                 NORAP epitopes 
The   simple method among all these in identifying the NORs 
is the silver staining technique. The structures demonstrated are 
called AgNORs (Argyrophilic Nucleolar Organizer Regions). This 
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silver staining technique identifies acidic NORAPs (Nucleolar 
Organizer Region Associated Proteins) seen in association with the 
site of RNA transcription. 
AgNORs are  aggregated tightly within one or two nucleoli in 
a normal cell, as seen in cytological smears . The number of 
AgNORs detected depends upon several of these factors. These 
include stage of the cell cycle, number of NORs bearing acrocentric 
chromosomes in their karyotype,  level of transcriptional activity of 
the cell. 
There is thus a remarkable difference between AgNOR counts 
in chromosome spreads and those observed in histology sections of 
the similar cell preparations. Since the AgNORs congregate within 
a relatively small nucleolus in histological sections, there is a 
greater difficulty in visualising the individual AgNORs. 
In malignant lesions, the AgNORs are dispersed throughout 
the nucleus to a varying extent, can easily visualised by the 
cytologists.  Therefore ‘AgNOR count’ in benign and malignant 
lesions does not denote the absolute number of AgNORs, but it is 
numerical index of dispersion of AgNORs within the nucleus. 
Dispersion in itself may reflect the proliferative state of the cell. 
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Hence the number of visible AgNORs indicates the number of cells 
in the current phase of transcription.  
HISTORY OF STAINING OF AGNOR  
By banding techniques Nucleolar organizing regions appeared 
as achromatic gaps on short arms of specific chromosomes when 
metaphase preparations were examined. Thus Howell et al felt the 
need for a technique to differentially stain these important regions. 
AS – SAT technique by already existing ammonia silver staining 
where satellites appeared as dark areas above kinetochore of 
Acrocentric chromosomes. 
Goodpasture and Bloom developed a simple silver staining 
technique in 1995 and they observed silver stained NORs 
(AgNORs) as black dots on yellow brown chromosome arms. Only 
transcriptionally active NOR’s bind silver 
Step I:  attachment of silver to  the protein nucleolin 
Step II:   Nucleation of further silver on the  bound metal,  
black appearance is seen 
Silver first binds carboxyl groups, then nucleates around 
disulfide and sulfhydryl groups.  
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It was postulated by Buys and Osinga that the AgNOR 
reaction involved protein moiety associated with a non-histone.as 
the reaction occurred extraction of histone .The reduction in silver 
solution  was brought about  by-COOH groups of the  non-histone 
proteins containing  
The silver deposits were in the form of large aggregates, 
which were seen at disulfide and sulfhydryl group site. Protein B23, 
C23 and RNA polymerase-1 are responsible for silver staining of 
nucleoli. 
An improved version of this method was developed by 
Howell and Black,77 which required two minutes to perform and 
used protective colloidal developer (gelatin, de iodized water and 
formic acid) to control reduction of silver. 
Ploton et al further simplified this technique by diminishing 
the staining temperature from 600C to 200C by which troublesome 
background staining was reduced, thereby aiding in better 
visualization of NOR’s. 
They applied silver staining technique to paraffin embedded 
tissue, permitted both a detailed study of nucleoli as well as study 
of the variation in size and AgNOR count in human tissues which 
 69 
showed the pathology, in comparison with normal tissue. A pilot 
study by them suggested that in prostatic carcinoma several 
AgNOR nuclear dots were seen.  
They opined that the easy applicability of AgNOR staining 
technique to, tissues with pathology, embedded in paraffin 
permitted the study of silver stainability and assess the relation to 
grading of cancer tissues and carcinoma in situ. This was modified 
technique by Ploton et al, adopted by most workers later.78 
Earlier workers counted 50, 100, and 200 nuclei. It was later 
found that the mean AgNOR with 100 nuclei obtained was the same 
as when only 50 were counted.80 
Crocker et al, described three types of AgNOR configuration 
• Solitary rounded argyrophilic structure corresponding to 
nucleolus.   The resting lymphocytes and benign cells are the 
ones in which these are seen. 
• Secondly, as often seen in proliferating cells NOR’s could be 
seen in the nucleus as partially dissociated foci. 
• Multiple small, discrete AgNORs may be seen distributed in 
whole of the nucleus. It is seen as a feature of malignant cells. 
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Based on this, they advised two ways of counting AgNORs 
Firstly, all silver stained structures should be counted, but when 
lying in groups each cluster should be treated as one structure. 
Secondly, where AgNORs can be seen separately within a 
nucleolus, each AgNOR could be counted as a unit, in addition to 
the smaller AgNORs seen outside the nucleoli. 
Hall et al81 obtained a linear correlation between Ki-67 
immuno reactivity and mean number of NOR in non-Hodgkin’s 
Lymphoma and suggested that NORs were possibly reflection of 
cellular kinetics. 
Smith and Crocker et al82 showed distinct variation between 
non neoplastic lesions, benign and malignant lesions Smith et al83 
studied the effect of a series of fixatives. Mercurial and dichromatic 
containing fixatives had detrimental effect while routine 10% 
normal saline gave good results. Alcohol gave optimal AgNOR 
staining. 
Howat et al84 found no correlation between AgNOR counts 
and prognosis in thick cutaneous malignant melanomas 
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An apparent increase in the mean AgNOR count was noticed 
in the cells under the following conditions: 
• When the cell proliferation was present, the nucleolar 
dissociation was present, and that the AgNORs were seen 
throughout the nucleus. 
• A defect of the nuclear association results in AgNOR dispersion 
throughout the nucleus. 
• An increase of the AgNOR bearing chromosomes resulting from 
increased cellular ploidy. 
In the benign neoplastic cells AgNORs are aggregated in a 
condensed small nucleus and hence show only 1-2 AgNOR per 
nucleus, which is attributed to the difficulty in visualising the 
individual NORs. While in malignancy, or in conditions of 
increased cellular proliferation, AgNORs get dispersed throughout 
the nucleus, enabling to enumerate them more easily.  The number 
of AgNORs detected depends upon several of these factors. These 
include- 
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1. The stage of the cell cycle.  
2. The number of NORs bearing acrocentric chromosomes 
in their karyotype 
3. The level of transcriptional activity of the cell. 
There is thus a remarkable difference between AgNOR counts 
in chromosome spreads and those observed in histology sections of 
the similar cell preparations. Since the AgNORs congregate within 
a relatively small nucleolus in histological sections, there is a 
greater difficulty in visualising the individual AgNORs. 
In malignant lesions, the AgNORs are dispersed throughout 
the nucleus to a varying extent, enabling them to be easily 
visualised by the cytologists. Therefore quantification of the 
AgNORs in interphase nuclei is probably related more to their 
dispersion throughout the nucleoplasm than to the actual number 
present in the nucleus. Therefore ‘AgNOR count’ in benign and 
malignant lesions does not denote the absolute number of AgNORs 
but it is rather a numerical index of dispersion of AgNORs within 
the nucleus. This connotes that dispersion in itself may reflect the 
proliferative state of the cell. Hence the number of visible AgNORs 
indicates the number of cells in the current phase of transcription. 
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AgNOR – TECHNICAL ASPECTS 
The advantage of the AgNOR staining technique is that, it is a 
one-step simple staining procedure.  It can also be used to 
demonstrate NORs on processed cytology smears and histology 
sections. The disadvantage is the time consuming process of 
counting of the little dots, often associated with inter-observer 
variations. 
This one step silver-staining method consist of a mixture of 
50% silver nitrate solution and 1% formic acid in 2gms% of gelatin 
solution which acts as a colloid stabilizer. These solutions have to 
be prepared separately and mixed freshly upon use. Cytological 
smears are incubated in the solution mixture for a period of 45 min 
and then washed, dehydrated, cleared and mounted for light 
microscopy examination.   
The NORs can be seen as discrete black / brown dots in a pale 
yellow background and can be enumerated using an oil immersion 
lens.  Counts of 50 neoplastic cells are made, under oil immersion 
and the results are recorded as a mean number of AgNORs 
visualised per nucleus.  
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This technique can be used with image analysis. In this 
technique the total amount of AgNOR per nucleus is measured. 
AgNOR STAINING REACTION & PROBLEMS: 
The silver staining technique is based upon the principle that, 
the silver salts as a result of their high electron charge density and 
by virtue of their phosphate moieties bind to the acidic NORAPs. 
Generally, the AgNOR silver staining method is been run for 
about 45minutes irrespective of whether cytological smears or 
histological sections were stained, but recently minor alterations 
have been put forth to reduce the staining time and also to 
incorporate internal controls to allow counting of subsidiary 
AgNOR dots. 
First, problem with the usage of any kind of silver staining 
method is the non-specific silver grain deposits in the background. 
Usage of clean glassware and very pure deionised water can 
overcome this background staining.  Modifications in the AgNOR 
staining method have been suggested that can solve this problem of 
background staining. These are: 
1. Usage of an inverted incubation technique, where the slides 
are inverted into the staining solution. This helps in 
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maintaining a high degree of contrast between the background 
and the AgNORs. 
2. Glycine blocks both free and reversibly bound aldehyde 
residues left over by formalin fixation, thereby reducing the 
background silver precipitation.  Pre-incubation with glycine 
prior to AgNOR staining can reduce the background stain. 
3. After completion of the staining procedure immersing the 
slides in a 10% nitric acid solution can minimise the 
background stain. 
4. Replacement of gelatin by polyethylene glycol as a protective 
colloidal developer medium. 
Second, the intensity of staining varies with variations of the 
staining time; which over-stained obscures the individually 
clustered AgNORs within nucleoli, or  under-stained renders them 
too faint . 
Third, in the histology sections  variations in the thickness of 
the sections affect the apparent number of AgNORs within the 
nuclei, thus requiring uniformly  thick section of around 3 - 4 µm.  
Cytology smears  doesn’t  face this issue. Thus AgNOR dot count 
study on cytological smears is more superior compared to those on 
histological sections. Cytological smears also show a better 
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discriminative value of AgNOR dots compared to those on 
histological sections. 
One great advantage of this technique is that, previously 
stained cytology slides can also be reused for silver staining, thus 
providing an excellent guide to the diagnosis especially in doubtful 
cases and when extra-unstained slides are not available. 
The major disadvantages are: 
1. Inter-observer variation is the major cause of inaccuracy and 
inconsistency. 
2. The counting procedures adopted are usually manual and are 
prone to subjective variations. 
3. Misjudged counts may result due to overlapping of the NORs 
within the nucleus. 
4. The dots of AgNOR in the interphase nuclei may not always 
correspond to the number of such types in the karyotype of 
the nucleus85. 
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MODIFICATIONS IN THE AgNOR TECHNIQUE: 
After the AgNOR technique was first described by Ploton in 
1986 it has undergone several modifications with an aim to improve 
the overall staining quality. Some of the modifications  are  
1. Combination of Feulgen reaction with modified AgNOR staining 
technique, which  enables the counting of active NORs and also 
the evaluation of the amount of DNA within the same cell 
nucleus by the Feulgen reaction. 
2. Combination of AgNOR staining technique with cytofluorometric 
analysis on cell suspensions. 
3. The use of AgNOR technique along with automatic image 
analysis software makes these technique far less prone to 
subjective errors than the traditional methods86. 
AgNOR - ENUMERATION 87 
The types of Nucleolar Organizer Regions within the nucleus 
can be categorized into three groups. 
The first one is the ‘Aggregated AgNOR’ which are seen as 
rounded, solitary structures and corresponds to the nucleolus of the 
cell, this type is often seen in resting cells and lymphocytes and the 
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individual NORs cannot be distinguished within the nucleus of 
these cells. 
The second type is the ‘Nucleolar pattern’ which is seen in 
the nucleus of the proliferating cells and the NORs are seen to be 
dispersed only within the nucleolus of the cell. 
Finally, the third type is the ‘True AgNORs’ that are seen to 
be dispersed throughout the nucleoplasm and are often seen in 
highly malignant neoplastic cells. These features can be 
demonstrated well in the cytological smears. 
METHODOLOGY: 
There are five methods for enumeration of AgNORs based on 
their count, morphology and distribution. They are 
1. Mean AgNOR count 
2. AgNOR proliferative index  
3. AgNOR size variation grading 
4. AgNOR distribution in the nuclei 
5. Subjective AgNOR Pattern Assessment (SAPA) 
Mean AgNOR count (mAgNOR): 
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Mean count of the number of NORs present in the nucleus of the 
50 neoplastic cells. mAgNOR value correlates with the mean DNA 
content of the cells indicating the cell ploidy. 
AgNOR proliferative index (pAgNOR): 
It is the percentage of neoplastic cells exhibiting more than 
five NORs within the nucleus of the 50 counted cells. pAgNOR 
value represents the number of cells in the S-phase fraction. 
AgNOR size variation and distribution grading: 
In 1991 – 1992 Ahsan et al utilised the criteria of size 
variation and distribution of AgNORs within the nucleus and 
demonstrated higher variation score of these parameters in 
malignant neoplasm compared to the benign counterparts. 
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TABLE 2 AgNORS SIZE VARIATION GRADING 
AgNOR Size Variation Score 
More or less uniform 0 
Two different sizes 1+ 
More than two different sizes (but not those of 3+) 2+ 
All grades and sizes including too minute to be 
counted 
3+ 
 
TABLE 3 AgNOR DISTRIBUTION IN THE NUCLEI 
AgNOR distribution – nuclei Score 
Limited to nucleoli 0 
Occasional dispersion outside nucleoli 1+ 
Moderate dispersion outside nucleoli 2+ 
Widely dispersed throughout the nucleus 3+ 
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Subjective AgNOR Pattern Assessment: 
Meehan et al proposed a method for scoring of AgNORs 
called ‘Subjective AgNOR Pattern Assessment (SAPA), which was 
based on morphological patterns, variation in the size and shape of 
the NORs, and whether they are aggregated or scattered 
The aim of the present study is to utilize AgNOR staining to 
identify alteration in Buccal mucosa in case of smokers and 
compare it with nonsmoker. 
In each slide, 50 nuclei were evaluated. The parameter was 
• Number of AgNOR dots in the nucleus. 
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MATERIALS AND METHODS 
The study was conducted after clearance from the 
Institutional ethical committee. 
The subjects were 75 male patients who attended ENT and 
Surgery OPD of Government Stanley Medical College, Chennai. 
INCLUSION  CRITERIA 
Cases were patients who smoked more than 20 cigarettes per 
day at least for the past 10years or more. 
EXCLUSION CRITERIA 
Exclusion criteria were applied and the patients rejected were 
cases of oral ulcer, with premalignant lesion such as leukoplakia, 
erythroplakia, oral malignancies, and patients with bleeding 
disorders 
CONTROLS 
 Non smokers were taken as controls. 
After a clinical examination and consent, the subjects were 
requested to gargle for 5 minutes. The lesional areas were wiped off 
using a sterile gauze piece. Cytological smears were taken from the 
buccal mucosa. The head of the cytobrush was moistened with 
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water and firmly held against the mucosa. Then, pressure was 
applied until bristles curled or tiny bleeding spots were evident. 
The brush was rolled for 10 full turns. The cytobrush was then 
rolled on glass slide by applying a continuous motion from one side 
to other. 
PREPARATION OF THE STOCK SOLUTION 
Preparation of stock solution A: 1% formic acid solution 
made by diluting 1ml of formic acid in 99 ml of distilled water. 2 
grams of gelatin powder was dissolved in 100ml of 1% formic acid 
solution. This comprised the Stock Reducing Solution. 
Preparation of Silver solution (solution B): A 50% solution 
of silver nitrate is prepared by dissolving 2 grams of crystalline 
silver nitrate in 4ml of distilled water. 
Preparation of silver colloidal staining solution: 4ml of 
freshly prepared solution B is mixed with 2ml of stock solution A 
and used immediately. 
METHODS OF STAINING 
Smears were layered with silver colloidal mixture. Slides 
were incubated in a dark room for 40 minutes at room temperature. 
 84 
The smears were washed in distilled water, dehydrated, 
cleared and mounted in D.P.X. The stained slides were viewed 
under 1000x magnification in oil immersion. 
AgNOR COUNTING METHOD 
Nucleolar organizing regions appeared as clear black dots in 
the nuclei. The counting was done based on Crocker’s method. The 
maximum number of clearly discernable AgNOR dots was 
ascertained in 50 nuclei at a magnification of 1000x.  
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OBSERVATION AND RESULTS 
TABLE4-CLASSIFICATION OF THE SUBJECTS  INTO 
GROUPS 
Study 
Groups 
Name 
of Group 
Observation  
Number 
of Subjects 
Group 
A 
Non -
smokers 
Agnor count in 
buccal mucosal cells 50 
Group 
B 
Smokers Agnor count in buccal mucosal cells 25 
 
 
 86 
STATISTICS  
Descriptive statistics was done for all data and suitable 
statistical tests of comparison were done. Continuous variables 
were analysed with the unpaired t-test and Pearson's R Correlation 
Test. Statistical significance was taken as P < 0.05. The data was 
analysed using EpiInfo software (7.1.0.6 version; Center for disease 
control, USA) and Microsoft Excel 2010. 
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CHART-1 –AGE DISTRIBUTION AMONG THE 
SUBJECTS 
 
 
TABLE5-AGE DISTRIBUTION OF THESUBJECTS 
INVOLVED IN THE STUDY 
Age Distribution Smoking - % Smoking + % 
21 to 30 10 20 1 4 
31 to 40 21 42 11 44 
41 to 50 18 36 9 36 
51 to 60 1 2 4 16 
Total 50 100 25 100 
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TABLE6-MEAN AND STANDARD DEVIATION OF THE 
SUBJECTS 
 Smoking - Smoking + 
N 50 25 
Mean 39.54 43.24 
SD 7.05723 8.222327 
P value 
Unpaired t test 
0.061198 
By conventional criteria the association between the groups 
and age is considered to be not statistically significant since p > 
0.05. 
CHART2-MEAN AgNOR COUNT AND STANDARD 
DEVIATION 
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TABLE7-MEAN AgNOR COUNT AND STANDARD 
DEVIATION 
 Smoking - Smoking + 
N 50 25 
Mean 2.36 3.45 
SD 0.16 0.18 
P value 
Unpaired t test 
0.0000 
 
TABLE 8-CORRELATION BETWEEN SMOKING AND 
AgNOR COUNT 
Pearson's R Correlation  Smoking - Smoking + 
Smoking - 1 
Smoking + 0.67367954 1 
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CHART 3 – AgNOR SCATTER PLOT 
 
By conventional criteria the association between the smoking 
and increase in AgNOR scores in buccal mucosa smears is 
considered to be statistically significant since p < 0.05. 
Statistical Significance 
This indicates that there is a true difference among treatment 
groups and the difference is significant. In simple terms, among 
smokers the AgNOR numbers in buccal mucosa smears are 
increased to 3.45±0.18 in comparison with non-smokers where 
AgNOR numbers in buccal mucosa smears are 2.36±0.16 on an 
average with a p-value of 0.0000 according to Unpaired t-test.  
There is a strong positive correlation between smoking and 
increase in AgNOR numbers in buccal mucosa smears. This is 
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indicated by the Pearson's R Correlation value of 0.67367954. This 
means as smoking increases the the AgNOR numbers in buccal 
mucosa smears increase. 
The percentage increase is also explained in the scatter plot. 
This linear model explains all the variability of the response data 
around its mean. Since R2 is 0.833, “the fitted regression equation 
explains 83.3% of the variation in Y".  
Clinical Significance 
• The AgNOR numbers in buccal mucosa smears was meaningfully 
more (46%) among smokers when compared to non-smokers.   
• The increase in AgNOR numbers in buccal mucosa smears 
correlates positively, directly and strongly with the quantum of 
smoking. This means that the 46% increase in AgNOR numbers in 
buccal mucosa smears due to smoking is true 67% of times 
• This 67% correlation of variation in AgNOR numbers in buccal 
mucosa smears among smokers is validated 83.3% of times.   
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CHART4-PROLIFERATIVE AgNOR 
 
 
TABLE9- MEAN AND STANDARD DEVIATION OF 
PROLIFERATIVE AGNOR 
Proliferative 
AgNOR Non smokers Smokers 
N 50 25 
Mean 7.56 16.24 
SD 1.42 1.67 
P value 
Unpaired t test 
0.0000 
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TABLE10 CORRELATION BETWEEN 
PROLIFERATIVE AgNOR AND SMOKING 
Pearson's r 
correlation  smoking - smoking + 
Non smokers 1  
Smokers 0.71999121 1 
 
This indicates that there is a true difference among treatment 
groups and the difference is significant. In simple terms, among 
smokers the percentage of cells with Proliferative AgNOR in buccal 
mucosa smears are increased to 16.24±1.67 in comparison with 
non-smokers where percentage of cells with PAgNOR Dots in 
buccal mucosa smears is 7.56±1.42 with a p-value of 0.0000 
according to Unpaired t-test.  
There is a strong positive correlation between smoking and 
increase in percentage of cells with PAgNOR(>5)  in buccal 
mucosa smears. This is indicated by the Pearson's R 
Correlation value of 0. 0.71999121. This means as smoking 
increases the proliferative AgNORin buccal mucosa smears 
increase. 
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CLINICAL SIGNIFICANCE 
• The Proliferative AgNOR in buccal mucosa smears was 
meaningfully more (2.14 times) among smokers when 
compared to non-smokers.   
• The increase in proliferative AgNOR in buccal mucosa 
smears correlates positively, directly and strongly with 
smoking. This means that the 2.14 times increase in 
percentage of cells with>5 AgNOR in buccal mucosa smears 
due to smoking is true 72% of times 
 
 
 
 
 
 
 95 
DISCUSSION 
Squamous cell carcinoma is the most frequent malignancy of 
mouth among the ten most common cancers in the world93. A strong 
causal relationship exists between cigarette smoking and 
development of oral squamous cell carcinoma. 
Head and Neck malignancies is one of the most common 
entity, currently holding sixth position in the worldwide 
stastistics94. Cancer of the oral cavity is more common in the Indian 
scenario and accounts for one third of cancer cases. 90% of patients 
are smokers and tobacco chewers95. 
Screening can reduce morbidity and mortality in oral cancers. 
The most common diagnostic tool is biopsy which is a painful 
invasive procedure. It can be substituted by exfoliative cytology 
which is a easy and cheap modality. It can be carried out with a 
cytobrush and is a useful non- invasive technique for detecting 
early and suspicious oral lesions.  
Exfoliated cells from oral epithelium have been widely used 
to detect abnormal nuclear and cellular morphology to identify 
precancerous and cancerous changes. Buccal mucosal cells are 
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widely affected, as more surface area is exposed to the insult and 
that the epithelial cells are non- keratinized make them vulnerable 
to changes due to smoking. 
A potent biomarker for measuring the cell activity 
proliferating potential of cells is AgNOR. AgNOR is associated 
with acidic, argyrophilic, nonhistone proteins that can be visualized 
by using silver staining technique. 
Silver staining method for identification of NOR in 
exfoliative cytology is being recently used to know the cellular 
changes due to smoking. Benign tumor cells exhibit less number of 
dots per nucleus, roundedness and clustered distribution. Malignant 
cells show large number of dots per nucleus, irregular shape of 
AgNOR and scattered distribution. 
In our study of AgNOR counting using crockers method was 
done on 75 samples taken from 50 non -smokers and 25 smokers. 
Sampio et.al  conducted their study in 1999 ,with 20 smokers 
and non- smokers. AgNOR staining was carried out. 100 cells were 
taken into account for counting. The inference was that AgNOR 
expression was high in smokers. The percentage of cells with 
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AgNORs numbering more than 5 per nucleus are indicative of high 
proliferative activity in smokers. 
A total of 60 smokers and non- smokers were chosen for 
evaluation of AgNOR staining of buccal mucosal cells by 
Jahenshah Salehinejad et.al showed a mean AgNOR higher in 
smokers than non- smokers. A percentage of cells with 3 or more 
AgNOR stained dots were determined. 
In a study by Ufuk USTA, 116 patients were selected of 
which 55 were smokers and 61 were nonsmokers. Smokers chosen 
for this study were found to use 20 filtered cigarettes per day for 
past 20 years. A total of 200 cells were taken into account for this 
study and proliferative AgNOR was observed in their study. 
55 subjects, 40 patients with history of smoking and tobacco 
chewing, 10 normal healthy patients and 5 patients with oral SCC 
were included in a study conducted by anushree sharma and 
sushmita saxena. AgNOR counting was done in 50 non overlapping 
cells. The percentage of cells with more than 3 and more than 5 
nuclei were seperately calculated.. 
A study by sethi and shah et.al included 30 smokers and 30 
non -smokers and counted 100 cells. They concluded mean AgNOR 
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was higher in smokers than non -smokers. There was a rise in 
proliferative AgNOR in smokers. 
Sachin Jindal et.al. worked on 25 smokers and 25 non-
smokers. 500 cells per slide was counted to note changes. The 
smokers had the habit for 5 to 10 years and ranged from 5 to 20 
cigarettes. The mean AgNOR were on the higher side for smokers 
in comparison with non- smokers. 
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TABLE-11-A COMPARISON OF MEAN AGNOR IN 
VARIOUS STUDIES 
S.NO STUDY MEAN AgNOR     SMOKERS 
MEAN AgNOR 
NONSMOKERS 
1. Sampio et.al91 3.4+/-0.54 2.6+/-0.49 
2. Jahenshah 
sulehinejad et.al92 
3.6+/-0.43 1.96+/-0.14 
3.  Sachin Jindal 
et.al93 
4.162+/-0.532 3.352+/-0.760 
4. Sethi and shah 
et.al94 
3.79+/-0.480 2.94+/-0.325 
5. UfukUSTA et.al95 4.22+/-0.39 3.47+/-0.30 
6. Sharma et.al96 3.35+/-0.38 2.91+/-0.23 
7. Present study 2.36+/-0.16 3.45+/-0.18 
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TABLE12-A COMPARISON OF PROLIFERATIVE 
AGNOR IN VARIOUS STUDIES 
S.NO STUDY 
PROLIFERATIVE 
AgNOR   (>5)  
SMOKERS  
PROLIFERATIVE 
AgNOR(>5) 
NONSMOKERS 
1. Sampio et.al 20% 6% 
3.  Sethi and shah 
et.al 
26.5% 11.7% 
4. UfukUSTAet.al 36.8% 14.6% 
5. Present study 16.24% 7.56% 
Zimmerman and Zimmerman observed that age smoking 
habit, oral and systemic disease modified the degree of 
keratinization of oral mucosa at certain sites. 
Study conducted by Sampios included patients ranging from 
41 to 77 with a mean age of 57 in the non-smoking group and 40 
to76 years with a mean of 53 years in the smoking group. AgNOR 
expression was not found to be influenced by age factor. 
In the present study, subjects ranging from 28 to 58 years 
were taken. The mean age for smokers was 43.24 years and for non-
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smokers was 39.54 years. There was no significant correlation 
between age and the expression of AgNOR in this study. 
According to world health organization, over 1 billion people 
are associated with tobacco smoking. More than 20 cigarettes per 
day increases the risk of oral cancer. It has been observed that more 
than 4 to 5 million deaths per year occurs due to smoking. This 
number is estimated to increase to 10 million by 2030. Second hand 
smoking may also increase a person’s risk of head and neck cancer. 
Smokers taken up for the study by UfukUSTA were found to 
smoke 20 filtered cigarettes per day for past 20 years. 
Jahenshah included smokers using a minimum of 20 
cigarettes per day for 10 years. 
In our present study group, samples were taken from patients 
who were chronic smokers for more than 10 years and smoked a 
minimum of 20 cigarettes per day. 
Poor oral hygiene increases the risk of oral cancers. Poor 
dental health or prolonged irritation from ill- fitting dentures in 
tobacco smokers contributes to oral cancer. 
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Poor nutrition and weakened immune system also predisposes 
to higher risk of developing oral cancer. In a study conducted by 
Lynne Adikins observed that poor oral hygiene leads to more than 
50% chance of occurrence of oral HPV infection. 
Castro Sampio and Jahenshah observed that there were no 
oral or systemic disease in their patients. 4 patients were observed 
to present with poor oral hygiene in our study and the AgNOR 
count was observed to be high in such patients  . 
Mean AgNOR count is a valuable criterion for defining 
objective parameters for the diagnosis of premalignant and 
malignant lesions of oral cavity. 
Remmerbach et.al inferred a mean AgNOR of 2.31+/-0.7 in 
non- smokers and 3.39+/-0.4 in smokers. A similar observation was 
made by Mao et.al. He observed a mean AgNOR of 2.44+/-0.3 in 
non- smokers and 4.69+/-0.72 in case of oral cancer. 
The mean AgNOR in smokers was found to be 3.79+/-0.48 
and in non- smokers it was 2.94 +/- 0.325 in a study conducted by 
sethi and shah et.al. 
Studies by Jahenshah et.al revealed a mean AgNOR of 
1.96+/-0.14 in non- smokers and 3.6+/- 0.43 in smokers. 
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Studies by Chattopadhyaya et.al showed a mean AgNOR of 
2.732 +/- 0.236 in non-smokers and 3.372 +/- 0.375  in case of 
smokers. 
Xin Xie made an observation of mean AgNOR of 2.3+/- 0.4 
in case of non-smokers and 3.8+/- 0.8 in case of dysplasia. 
AgNOR expression  in the study by sachin Jindal showed a 
mean AgNOR of 4.162+/- 0.53 and 3.352+/-0.76. 
Studies by sharma et.al showed a mean AgNOR of 3.35+ /-
0.38 in smokers and 2.91+/- 0.23 in non smokers. 
The observations made by UfukUSTAet.al showed a mean 
AgNOR of 4.22+/- 0.39 in case of smokers and 3.47 +/- 0.3 in case 
of non-smokers. 
In comparison with other studies the present study showed a 
similarity to the studies of  Mao et.al, Remmerbach et.al, Sampio 
et.al,and Sharma et.al and Jahenshah et.al, Xin xie et.al, while 
higher mean AgNOR value was observed in studies conducted by 
Sachin Jindal et.al  and UfukUSTA et.al.  
Proliferative AgNOR is one another parameter which is a 
reflection of the proliferative activity of the cell. It can be 
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calculated by enumerating the number of cells with greater than 5 
AgNOR dots per cell. It can also be done for greater than 3 AgNOR 
dots per cell. 
The proliferative AgNOR  in Sampio et.al study was 20% in  
smokers and 6% in non smokers. In the study by Sethi and Shah 
et.al it was 26.5% in smokers and 11.7% in nonsmokers. 
The present study showed a proliferative AgNOR of 16.24 % 
and 7.56% in smokers and non-smokers respectively.    
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SUMMARY  
This prospective study was carried out at government Stanley 
medical college over a period of 12 months from 2013 to 2014. 
AgNOR expression was observed in both smokers and non-
smokers. 
This study has helped us in to make the following 
interpretation. 
1. 50 Non overlapping cells were taken for the study in each 
smear. 
2. Age did not have a significant impact in the expression of 
AgNOR per    nucleus. 
3. High mean AgNOR count was seen in smokers for more 
than 10 years and who used a minimm of 20 cigarettes per 
day. 
4. The mean AgNOR count in smokers was 3.45+/-0.18and in 
non smokers was 2.36+/-0.16  
5. The proliferative AgNOR was 16.24% in smokers and 
7.56% in non smokers. 
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CONCLUSION  
This study supports and extends the view that cytological 
changes seen in oral mucosa due to smoking detected by AgNOR 
application serves as a useful, simple, preliminary diagnostic aid in 
observing changes in apparently normal buccal mucosa and 
assessing it as a risk factor in progression to cancer.  
It also supports the expectation that AgNOR as a biomarker 
for proliferative changes in normal buccal mucosa, will prove 
beneficial in smoking cessation counselling. 
 
 
 
 SMEAR SHOWS 4 TO 5 AgNOR DOTS PER NUCLEUS  
(X 1000) IN SMOKERS 
 
 
SMEAR SHOWS 5 TO 6 AgNOR DOTS PER NUCLEUS (X 1000) 
IN SMOKERS 
  
 
 
 
 
 
 
 
 
 
 
 
LOW POWER VIEW O F AGNBOR  
 
 
  
SMEAR SHOWS 1 TO 2 AgNOR DOTS PER NUCLEUS OF EVEN 
SIZE AND SHAPE (X 1000) IN NON SMOKERS 
 
 
 
SMEAR SHOWS 3 TO 4 AgNOR DOTS PER NUCLEUS OF EVEN 
SIZE AND SHAPE (X 1000) IN NON SMOKERS 
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SL.NO. AGE/SEX SM/NSM mAgNOR pAgNOR
1 30/M NSM 2.28 4
2 3O/M NSM 2.32 3
3 45/M NSM 2.56 5
4 35/M NSM 2.46 4
5 50/M SM 3.22 8
6 28/M NSM 2.34 3
7 27/M NSM 2.26 4
8 48/M SM 3.48 9
9 50/M NSM 2.38 4
10 29/M NSM 2.22 3
11 35/M SM 3.44 8
12 31/M NSM 2.42 3
13 40/M NSM 2.32 4
14 44/M SM 3.36 7
15 38/M SM 3.42 8
16 30/M SM 3.32 7
17 35/M SM 3.46 9
18 31/M SM 3.52 10
19 37/M SM 3.42 9
20 43/M SM 3.28 8
21 58/M SM 3.76 9
22 50/M SM 3.64 8
23 36/M SM 3.14 7
24 50/M  SM 3.5 8
25 40/M SM 3.06 7
26 53/M SM 3.74 9
27 40/M NSM 2.76 5
28 46/M NSM 2.72 4
29 50/M NSM 2.4 4
30 46/M NSM 2.32 3
31 38/M NSM 2.44 4
32 29/M NSM 2.28 3
33 47/M NSM 2.39 4
34 28/M NSM 2.08 3
35 32/M NSM 2.14 3
36 33/M SM 3.34 8
37 40/M SM 3.42 8
38 50/M SM 3.72 9
39 38/M SM 3.68 8
40 48/M NSM 2.48 4
41 30/M NSM 2.56 3
42 35/M NSM 2.24 4
43 30/M NSM 2.34 4
44 35/M SM 3.26 7
45 50/M NSM 2.16 5
46 54/M SM 3.42 7
47 53/M SM 3.64 8
48 50/M SM 3.52 9
49 40/M NSM 2.54 4
50 50/M SM 3.38 8
51 43/M NSM 2.04 4
52 40/M NSM 2.32 5
53 45/M NSM 2.44 5
54 40/M NSM 2.16 4
55 34/M NSM 2.42 4
56 35/M NSM 2.26 3
57 50/M NSM 2.32 3
58 40/M NSM 2.2 3
59 44/M NSM 2.56 5
60 34/M NSM 2.54 4
61 36/M NSM 2.36 3
62 41/M NSM 2.42 3
63 48/M NSM 2.08 3
64 45/M NSM 2.52 4
65 50/M NSM 2.18 3
66 54/M NSM 2.4 3
67 38/M NSM 2.26 4
68 34/M NSM 2.38 5
69 42/M NSM 2.46 5
70 44/M NSM 2.54 4
71 40/M NSM 2.16 3
72 36/M NSM 2.34 4
73 33/M NSM 2.56 4
74 30/M NSM 2.2 3
75 37/M NSM 2.64 4
